Data is not available at this time.
Concentra Group Holdings Parent, Inc. operates in the healthcare services sector, specializing in occupational health, urgent care, and physical therapy. The company generates revenue through a fee-for-service model, catering primarily to employers, insurers, and individual patients. Its integrated network of clinics provides cost-effective, high-quality care, positioning Concentra as a leader in workplace health solutions. The company differentiates itself through scalable operations, proprietary technology, and strategic partnerships with large employers and payers. In a competitive and fragmented market, Concentra leverages its national footprint and standardized care protocols to maintain a strong market position. The demand for occupational health services is driven by regulatory requirements and employer wellness initiatives, providing a stable revenue base. Concentra’s focus on operational efficiency and patient outcomes supports its reputation as a trusted provider in the industry.
Concentra reported revenue of $1.90 billion for FY 2024, with net income of $166.5 million, reflecting a net margin of approximately 8.8%. The company generated $274.7 million in operating cash flow, demonstrating solid cash conversion. Capital expenditures of $64.3 million indicate disciplined reinvestment in clinic infrastructure and technology. These metrics underscore Concentra’s ability to balance growth with profitability.
Diluted EPS stood at $1.31, supported by efficient capital allocation and scalable operations. The company’s ability to generate consistent earnings highlights its operational leverage in a capital-intensive industry. Concentra’s focus on high-return investments, such as clinic expansions and technology upgrades, enhances its long-term earnings potential.
Concentra held $183.3 million in cash and equivalents, against total debt of $1.95 billion, indicating a leveraged but manageable capital structure. The company’s ability to service debt is supported by stable cash flows. Prudent financial management will be critical to maintaining liquidity and flexibility amid industry headwinds.
The company’s growth is driven by organic clinic expansions and strategic acquisitions. A dividend of $12.05 per share signals confidence in sustained cash flow generation. Concentra’s focus on recurring revenue streams from employer contracts provides visibility into future growth.
The market likely values Concentra based on its stable cash flows and leadership in occupational health. Investors may focus on the company’s ability to maintain margins amid labor cost pressures and regulatory changes. The dividend yield and earnings consistency are key valuation drivers.
Concentra’s national scale, integrated care model, and employer relationships provide durable competitive advantages. The outlook remains positive, supported by demand for workplace health services and operational efficiency initiatives. Risks include regulatory changes and labor market dynamics, but the company is well-positioned to navigate these challenges.
Company filings, CIK 0002014596
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |